A study to evaluate the effectiveness of booster vaccination, compared with that of two-dose primary series alone, against symptomatic SARS-CoV-2 infection and Covid-19-related hospitalization and death during a large wave of omicron infections
Latest Information Update: 25 Mar 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 25 Mar 2022 New trial record
- 09 Mar 2022 Results published in the New England Journal of Medicine